E.g., 26-07-2021
E.g., 26-07-2021
We have found 71 results.
View by: Grid List
Sort by: Relevancy Date
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    Strategy Monthly: Trading On European Diversity

    The European economic recovery has matured into a sustained, broad-based expansion, and the risks from politics and ECB policy normalization are modest. But eurozone equity indexes have not done well. In relative terms, they started trading sideways after Macron's victory in the French election last May, and for the past several months they have underperformed. The fault lies in the indexes, not in Europe's corporate sector. The...

    0
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    Strategy Monthly: Portfolio Strategy For An Inflationary World

    Most money managers today have spent their entire careers in the disinflationary environment that has prevailed since the mid-1980s, in which equities prospered and bonds were an ideal hedge. This may soon change. A growing number of signals point to rising inflation and tighter liquidity. If we really do move into an inflationary era, managers will have to rethink their portfolios from the ground up. In the latest Strategy Monthly, Louis and...

    0
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    Strategy Monthly: Everything Looks Fine, But…

    The year has opened with growth expectations and risk appetites at their highest levels in years. The consensus is probably right that it will be a good year for economies and stock markets. The main thing to watch out for is a faster-than-expected withdrawal of QE and low-interest rate policies by the ECB and the BOJ, which could send US bond yields sharply higher.

    0
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    Strategy Monthly: The Long Cycle Continues

    As equity markets everywhere continue to trade higher, money managers are getting increasingly nervous about how long the rally can last. In December’s Strategy Monthly, Anatole argues that we are still only half-way through a secular bull market that can last through the end of the decade. With further US rate hikes on the cards, barring any nasty surprises non-US markets are likely to outperform going forward. The only fly in the ointment is...

    0
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    Strategy Monthly: How Much Longer For Low Rates?

    For decades fixed income and equity markets have enjoyed a secular bull market, propelled higher by low real long term interest rates, depressed by a glut of global savings. In this Strategy Monthly, Will Denyer updates his Capital Provider Ratio, a powerful demographic tool which indicates that the growth of global excess savings has peaked, and that the glut will soon begin to dry up, with far-reaching consequences for global asset markets.

    0
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    Strategy Monthly: Japan Is Back!

    For a quarter of a century, Japan has been stuck in a structural malaise, and the only assets you wanted to own were Japanese government bonds. Charles believes this era is over. Corporate profits are at a record high relative to GDP and seemingly headed higher; the yen is the cheapest it has been, on a purchasing-power basis, since 1985. The yen could well be the best performing currency over the next few years, but is so undervalued that even...

    0
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    Strategy Monthly: A Two-Legged Equity Bull Market

    For the past several years, the brightest spot in global equity markets has been the US, and in particular tech and consumer stocks. This is changing, and we now have a "two-legged" equity bull market led both by US tech stocks and by a resurgent Asia. In our review of global investment conditions Louis explains why this is so, and argues none of the obvious land mines is likely to go off at any time soon.

    0
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    Strategy Monthly: India — Poised For A Pickup

    India clearly offers one of the best long-term growth stories in the world today. In 2016 for the first time it added more to global nominal GDP growth than China. Demographics are favorable, opportunities for infrastructure- and housing-driven growth are abundant, and despite some hiccups the Modi government has done a good job of taming inflation and setting the country on a structurally sounder path. For investors, the problem is that Indian...

    0
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    Strategy Monthly: The China Markets Opportunity

    The doors to China’s capital markets are opening wider, with MSCI adding A-shares to its indexes, and the Bond Connect program launching in Hong Kong. In this Strategy Monthly, Thomas Gatley and Chen Long explain how foreign investors should position themselves in Chinese bonds and equities in light of these new market-opening measures.

    0
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    Strategy Monthly: Building A Globally Diversified Portfolio

    Successful money management is more about avoiding losers than picking winners. The winners of the last decade have mainly been large-cap US equities; this increases the odds that they will underperform in coming years. In this edition of the Strategy Monthly Louis Gave recommends a rotation into eurozone equities, and EM stocks and yield plays (especially in Asia).

    0
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    Strategy Monthly: Global Goldilocks And The Two Bears

    Markets seem convinced that a Global Goldilocks scenario of “just right” growth and rising corporate earnings is unfolding. This is plausible, but a careful review of the US economy suggests that two far more bearish outcomes are also possible. Will Denyer reviews the case for all three scenarios and recommends reducing risk exposure, especially in the US.

    0
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    Strategy Monthly: Europe Braces For The French Election

    The macroeconomic stars are aligning for the eurozone. The region’s cyclical recovery is extending itself across economies and sectors alike. Inflation remains modest, reducing the chances of an early monetary tightening. Eurozone equities are relatively cheap in an expensive world. And the euro is fundamentally undervalued against the US dollar. However, the big risk for investors remains the possibility that nationalist euroskeptic Marine Le...

    0
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    Strategy Monthly: Reflation Gets A China Boost

    For the last three months, markets have been focused on “Trumpflation”. But the global reflation trade began long before Donald Trump’s November election, with China’s surprisingly strong growth rebound early last year. This suggests that China’s growth performance in 2017 will be a key factor in determining the sustainability of global reflation. In this edition of Gavekal’s Strategy Monthly, Arthur Kroeber and Chen Long argue that China’s...

    0
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    Strategy Monthly: Beyond The Trump Rally

    We have revamped the format of our Monthly to make it a more useful guide to our key investment views. In this month's edition, Louis Gave looks beyond the temporary euphoria that gripped markets after Donald Trump's election and sketches out investment strategies for the coming year.

    0
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    The Gavekal Monthly: Our Top 12 Questions For 2017

    For our first Monthly of the year, we depart from our normal format to offer our thoughts on the dozen most important questions investors must face this year. Not surprisingly, the issues that rose to the top were the impact of the new Trump administration's policies on the dollar and US bond yields, and whether the eurozone will spend the year tearing itself apart. Also,oil prices, the risk of financial implosion in China, and where to...

    2
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    The Gavekal Monthly: Preparing For The Trumped-Up Economy

    Markets have been on a startling trajectory since Donald Trump upended investors’ assumptions with his win in the US presidential election. In this issue of the Monthly two Gavekal partners ask whether the macro environment really has fundamentally shifted due to the emerging policy platform of the president-elect.

    0
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    The Gavekal Monthly: Deflation Ends; What Next?

    The biggest market move of the past month was a significant rise in bond yields across the US and Europe. Much commentary has suggested that this might be a symptom of a sustained rise in inflationary pressures, as wages and rents start to push up prices in the US, and Chinese producer prices end four long years spent in negative territory. We are skeptical. The recent rise in yields has so far reversed only half of the decline in the first half...

    0
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    The Gavekal Monthly: What Price On A Trump Victory?

    Markets seem sanguine about the prospect of a Donald Trump victory in next month's US presidential election—too sanguine. Expert opinion gives Hillary Clinton a 75% chance of winning. But remember that four months ago in the UK, expert opinion discounted polls showing a strong chance of Brexit, and the experts were proved wrong. And the consequences of a Trump win are so huge and potentially destabilizing that even a 25% chance means...

    0
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    The Gavekal Monthly: How Long Can The Rally Last?

    Investors enjoyed a surprisingly upbeat summer with the World MSCI close to an all-time high and emerging markets continuing to benefit disproportionately. Yet with the Federal Reserve sounding increasingly hawkish, earnings looking soft and political uncertainty remaining the order of the day, this Gavekal Monthly focuses on threats to the current benign market mood.

    0
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    The Gavekal Monthly: Shall We Dance?

    In a world in which the Fed shows no inclination to get ahead of the curve on inflation and in which both the ECB and the BoJ are in full quantitative easing mode, investors everywhere are on the hunt for yield. But the chase is a nervous one. Investors are all too aware that equities and bonds are sending conflicting signals, and that the favorable trends that have lifted most assets over the last six months could be disrupted by a sudden spike...

    0
Show me: results